These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
187 related items for PubMed ID: 27503376
1. Osteokeratoprosthesis Using Tibial Bone: Surgical Technique and Outcomes. Charoenrook V, Michael R, de la Paz MF, Ding A, Barraquer RI, Temprano J. Ocul Surf; 2016 Oct; 14(4):495-506. PubMed ID: 27503376 [Abstract] [Full Text] [Related]
2. Comparison of long-term results between osteo-odonto-keratoprosthesis and tibial bone keratoprosthesis. Charoenrook V, Michael R, de la Paz MF, Temprano J, Barraquer RI. Ocul Surf; 2018 Apr; 16(2):259-264. PubMed ID: 29501483 [Abstract] [Full Text] [Related]
4. Impact of clinical factors on the long-term functional and anatomic outcomes of osteo-odonto-keratoprosthesis and tibial bone keratoprosthesis. De La Paz MF, De Toledo JÁ, Charoenrook V, Sel S, Temprano J, Barraquer RI, Michael R. Am J Ophthalmol; 2011 May; 151(5):829-839.e1. PubMed ID: 21310387 [Abstract] [Full Text] [Related]
6. Osteo-odonto-, Tibial bone and Boston keratoprosthesis in clinically comparable cases of chemical injury and autoimmune disease. de la Paz MF, Salvador-Culla B, Charoenrook V, Temprano J, Álvarez de Toledo J, Grabner G, Michael R, Barraquer RI. Ocul Surf; 2019 Jul; 17(3):476-483. PubMed ID: 30986549 [Abstract] [Full Text] [Related]
9. Glaucoma Risk Factors and Outcomes Following Boston Keratoprosthesis Type 1 Surgery. Geoffrion D, Harissi-Dagher M. Am J Ophthalmol; 2021 Jun; 226():56-67. PubMed ID: 33493469 [Abstract] [Full Text] [Related]
10. Long-Term Outcomes of Keratoprosthesis With Biological Haptic: A Review of 25 Years of Single-Center Surgeries. Angerer MPM, Weller JM, Kruse FE, Hille K. Cornea; 2024 Sep 01; 43(9):1137-1143. PubMed ID: 38391267 [Abstract] [Full Text] [Related]
13. Long-Term Outcomes of the Boston Type I Keratoprosthesis in the Management of Corneal Limbal Stem Cell Deficiency. Aravena C, Bozkurt TK, Yu F, Aldave AJ. Cornea; 2016 Sep 01; 35(9):1156-64. PubMed ID: 27387566 [Abstract] [Full Text] [Related]
14. Long-term visual outcomes of the Boston type I keratoprosthesis in Canada. Szigiato AA, Bostan C, Nayman T, Harissi-Dagher M. Br J Ophthalmol; 2020 Nov 01; 104(11):1601-1607. PubMed ID: 32066560 [Abstract] [Full Text] [Related]
15. Long-Term Visual Outcomes, Complications, and Retention of the Boston Type I Keratoprosthesis. Aravena C, Yu F, Aldave AJ. Cornea; 2018 Jan 01; 37(1):3-10. PubMed ID: 28990994 [Abstract] [Full Text] [Related]
17. Outcomes After Auro Keratoprosthesis Implantation: A Low-Cost Design Based on the Boston Keratoprosthesis. Venugopal A, Rathi H, Rengappa R, Ravindran M, Raman R. Cornea; 2016 Oct 01; 35(10):1285-8. PubMed ID: 27429086 [Abstract] [Full Text] [Related]
18. Boston type 1 keratoprosthesis: the university of california davis experience. Bradley JC, Hernandez EG, Schwab IR, Mannis MJ. Cornea; 2009 Apr 01; 28(3):321-7. PubMed ID: 19387235 [Abstract] [Full Text] [Related]
19. Predictors of visual outcomes following Boston type 1 keratoprosthesis implantation. Ahmad S, Akpek EK, Gehlbach PL, Dunlap K, Ramulu PY. Am J Ophthalmol; 2015 Apr 01; 159(4):739-47. PubMed ID: 25555801 [Abstract] [Full Text] [Related]
20. Evaluation of a low-cost design keratoprosthesis in end-stage corneal disease: a preliminary study. Sharma N, Falera R, Arora T, Agarwal T, Bandivadekar P, Vajpayee RB. Br J Ophthalmol; 2016 Mar 01; 100(3):323-7. PubMed ID: 26271267 [Abstract] [Full Text] [Related] Page: [Next] [New Search]